申请人:Warner-Lambert Company
公开号:US04761424A1
公开(公告)日:1988-08-02
The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
本发明涉及新型烯酰胺类化合物、药物组合物及其使用方法,适用于治疗疾病,其中脂氧酶酶活性产物或白三烯的作用促成了病理状况。